AFYX unveils positive study results for Rivelin Patch in treating mucosal diseases
The preclinical study shows potential to deliver anti-TNFα antibody fragments to inflamed mucosal tissue using Rivelin technology
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Sep 21
The preclinical study shows potential to deliver anti-TNFα antibody fragments to inflamed mucosal tissue using Rivelin technology
24 Aug 21
The vaccine, ZyCoV-D, is exclusively administered using the PharmaJet Tropis® Needle-free Injection System
11 Aug 21
As new and novel drug therapies are developed to address areas where conventional medicines are limited, drug delivery…
06 Aug 21
The new facility will allow Berry Global to expand its R&D expertise and scale up production in various…
29 Jul 21
Hengyu provides elastomeric and plastic components used in injectable drug delivery
27 Jul 21
The Prevail DCB is designed to treat narrowed or blocked coronary arteries in patients with coronary artery disease
26 Jul 21
The company has agreed to acquire up to 64.6% share capital in Voluntis by paying €8.70 per share
26 Jul 21
Ensemble is the first transdiagnostic PDT for MDD and GAD available in the US
23 Jul 21
The Insignis syringe infusion system is also suitable for lengthy low-volume hospital infusions
21 Jul 21
Terumo and UMCU previously partnered for technology transfer, product development and to advance clinical evidence in several oncology…